| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,851 |
5,703 |
$730K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
13,293 |
1,628 |
$388K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,611 |
7,604 |
$275K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,931 |
1,221 |
$243K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,562 |
8,071 |
$234K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,143 |
5,426 |
$221K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,763 |
1,155 |
$161K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
920 |
720 |
$143K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,784 |
1,211 |
$141K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,581 |
1,247 |
$100K |
| 80053 |
Comprehensive metabolic panel |
12,887 |
9,655 |
$97K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,821 |
11,941 |
$92K |
| 71045 |
Radiologic examination, chest; single view |
2,423 |
1,809 |
$83K |
| G0378 |
Hospital observation service, per hour |
342 |
300 |
$68K |
| 86063 |
|
12,209 |
10,135 |
$67K |
| 71046 |
Radiologic examination, chest; 2 views |
2,122 |
1,678 |
$62K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,084 |
2,269 |
$56K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,120 |
584 |
$51K |
| 70450 |
Computed tomography, head or brain; without contrast material |
652 |
562 |
$49K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
440 |
260 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
19,928 |
14,596 |
$45K |
| 83880 |
|
1,788 |
1,354 |
$43K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
429 |
352 |
$41K |
| 83735 |
|
8,326 |
6,070 |
$37K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
390 |
224 |
$35K |
| 80061 |
Lipid panel |
3,373 |
2,913 |
$30K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
273 |
95 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
548 |
258 |
$29K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
291 |
148 |
$29K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
113 |
105 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,441 |
3,001 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,723 |
1,492 |
$20K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,009 |
2,438 |
$18K |
| 84484 |
|
2,039 |
1,317 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
672 |
565 |
$17K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
672 |
565 |
$17K |
| 81001 |
|
6,494 |
5,531 |
$17K |
| 82553 |
|
1,909 |
1,225 |
$16K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
782 |
681 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
281 |
227 |
$11K |
| 82550 |
|
2,017 |
1,312 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
475 |
325 |
$10K |
| 87807 |
|
800 |
671 |
$9K |
| 73560 |
|
214 |
166 |
$8K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
487 |
74 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
340 |
328 |
$6K |
| 97116 |
|
543 |
116 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
396 |
113 |
$5K |
| 80305 |
|
662 |
540 |
$5K |
| 82607 |
|
388 |
330 |
$4K |
| 81000 |
|
1,986 |
1,504 |
$4K |
| 81025 |
|
713 |
562 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
16 |
15 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
28 |
25 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,338 |
1,910 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$2K |
| 73630 |
|
66 |
52 |
$2K |
| 82728 |
|
166 |
161 |
$2K |
| 83550 |
|
251 |
240 |
$2K |
| 82150 |
|
284 |
236 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
41 |
36 |
$2K |
| 83540 |
|
251 |
240 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
36 |
34 |
$1K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
14 |
12 |
$1K |
| 97162 |
|
44 |
37 |
$1K |
| 87088 |
|
291 |
231 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
583 |
326 |
$1K |
| 83655 |
|
108 |
91 |
$1K |
| 82570 |
|
461 |
378 |
$1K |
| 85610 |
|
304 |
219 |
$1K |
| 96367 |
|
33 |
26 |
$978.60 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
446 |
351 |
$958.95 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
552 |
357 |
$803.48 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
934 |
519 |
$774.81 |
| 85018 |
|
465 |
349 |
$739.14 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
576 |
384 |
$707.22 |
| 93000 |
|
133 |
85 |
$702.23 |
| 87210 |
|
181 |
159 |
$691.18 |
| 84156 |
|
412 |
337 |
$674.61 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
653 |
525 |
$666.40 |
| 85014 |
|
396 |
295 |
$658.20 |
| 73030 |
|
14 |
12 |
$651.84 |
| 83690 |
|
155 |
128 |
$605.14 |
| 81002 |
|
293 |
225 |
$588.42 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
337 |
263 |
$393.12 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
23 |
12 |
$208.96 |
| 87077 |
|
28 |
25 |
$160.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32 |
18 |
$148.80 |
| 82746 |
|
13 |
12 |
$105.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
100 |
87 |
$98.53 |
| 82947 |
|
80 |
73 |
$47.87 |
| 87184 |
|
15 |
13 |
$40.38 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
416 |
138 |
$32.80 |
| 84550 |
|
21 |
12 |
$24.42 |
| 81015 |
|
157 |
118 |
$19.25 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
25 |
25 |
$8.80 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
31 |
24 |
$0.00 |
| 94760 |
|
36 |
14 |
$0.00 |
| 96376 |
|
78 |
31 |
$0.00 |